Polycystic ovary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.3 Inclusion Criteria (1) Women aged between 18 and 40; (2) Meet the diagnostic criteria of Western medicine for polycystic ovary syndrome; (3) BMI 25 kg/m2 or; (4) No hormone or lipid-lowering drugs were taken within 3 months before entering the study; (5) Patients signed informed consent and volunteered to take the test.
Exclusion criteria
Exclusion criteria: 1.4 Exclusion Criteria (1) persons younger than 18 or older than 40; (2) those who had used drugs and contraceptives affecting endocrine and lipid metabolism within 3 months before the study; (3) allergic to metformin; (4) Gynecological examination or B ultrasound examination of organic lesions of the uterus and accessories; (5) Diseases similar to the clinical and endocrine signs of PCOS due to other reasons, such as follicular membrane cell hyperplasia, ovarian or adrenal tumor, adrenal cortical hyperplasia, etc.; (6) patients with serious primary diseases such as heart disease, liver disease and kidney disease or mental illness; (7) Those who do not meet the inclusion criteria, do not use drugs as prescribed, cannot judge the efficacy or incomplete data affect the judgment of efficacy or safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate of clinical efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose;Follicle stimulating hormone;triglycerides;High-density lipoprotein;body mass index;TCM syndrome score;progesterone;Total cholesterol;weight;free fatty acids;testosterone;Estradiol;Prolactin;Waist hip ratio;Fasting insulin;Ovarian volume;Luteinizing hormone;Follicle diameter;Endometrial thickness;LH/FSH;Number of antral follicles;Low-density lipoprotein; | — |
Countries
China